A CYP21A2 based whole-cell system in Escherichia coli for the biotechnological production of premedrol by Simone Brixius-Anderko et al.
Brixius‑Anderko et al. Microb Cell Fact  (2015) 14:135 
DOI 10.1186/s12934‑015‑0333‑2
RESEARCH
A CYP21A2 based whole‑cell system 
in Escherichia coli for the biotechnological 
production of premedrol
Simone Brixius‑Anderko1, Lina Schiffer1, Frank Hannemann1, Bernd Janocha2 and Rita Bernhardt1*
Abstract 
Background: Synthetic glucocorticoids like methylprednisolone (medrol) are of high pharmaceutical interest and 
represent powerful drugs due to their anti‑inflammatory and immunosuppressive effects. Since the chemical hydrox‑
ylation of carbon atom 21, a crucial step in the synthesis of the medrol precursor premedrol, exhibits a low overall 
yield because of a poor stereo‑ and regioselectivity, there is high interest in a more sustainable and efficient biocata‑
lytic process. One promising candidate is the mammalian cytochrome P450 CYP21A2 which is involved in steroid 
hormone biosynthesis and performs a selective oxyfunctionalization of C21 to provide the precursors of aldosterone, 
the main mineralocorticoid, and cortisol, the most important glucocorticoid. In this work, we demonstrate the high 
potential of CYP21A2 for a biotechnological production of premedrol, an important precursor of medrol.
Results: We successfully developed a CYP21A2‑based whole‑cell system in Escherichia coli by coexpressing the 
cDNAs of bovine CYP21A2 and its redox partner, the NADPH‑dependent cytochrome P450 reductase (CPR), via a 
bicistronic vector. The synthetic substrate medrane was selectively 21‑hydroxylated to premedrol with a max. yield 
of 90 mg L−1 d−1. To further improve the biocatalytic activity of the system by a more effective electron supply, 
we exchanged the CPR with constructs containing five alternative redox systems. A comparison of the constructs 
revealed that the redox system with the highest endpoint yield converted 70 % of the substrate within the first 2 h 
showing a doubled initial reaction rate compared with the other constructs. Using the best system we could increase 
the overall yield of premedrol to a maximum of 320 mg L−1 d−1 in shaking flasks. Optimization of the biotransforma‑
tion in a bioreactor could further improve the premedrol gain to a maximum of 0.65 g L−1 d−1.
Conclusions: We successfully established a CYP21‑based whole‑cell system for the biotechnological production 
of premedrol, a pharmaceutically relevant glucocorticoid, in E. coli and could improve the system by optimizing the 
redox system concerning reaction velocity and endpoint yield. This is the first step for a sustainable replacement of a 
complicated chemical low‑yield hydroxylation by a biocatalytic cytochrome P450‑based whole‑cell system.
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Background
Since the 1950’s, the development of synthetic glucocor-
ticoids is of growing interest with the aim to substitute 
the natural steroid hormone hydrocortisone as therapeu-
tical compound. The superficial aim is to reduce severe 
hydrocortisone induced side effects, such as the distur-
bance of the electrolyte homeostasis, and to synthesize 
molecules with increased anti-inflammatory effects 
[1]. Based upon the artificial hydrocortisone derivative 
prednisolone the highly effective compound medrol 
(6-methylprednisolone) was developed by addition of 
a methyl group at carbon atom 6. Medrol turned out 
to have a far higher glucocorticoid activity than hydro-
cortisone without a comparative increase of electrolyte 
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activity [2]. Medrol was synthesized from its precur-
sor premedrol via a simple to perform biotechnological 
1,2 dehydrogenation [3]. Today, medrol is a widespread 
drug in the treatment of autoimmune diseases, allergic 
reactions, multiple sclerosis and rheumatic arthritis [4]. 
Therefore, the demand for this pharmaceutically highly 
relevant glucocorticoid is still increasing. One bottle-
neck during contemporary premedrol and, therefore, 
medrol production is the hydroxylation of carbon atom 
21. The chemical introduction of a hydroxyl group into 
a steran scaffold consists of a multistep-synthesis with 
the necessity to apply protecting groups and toxic com-
pounds like iodine [5]. As by-products occur after each 
reaction step, a time consuming chromatographic puri-
fication is necessary, which leads to a reduced overall 
yield and a low efficiency factor [6, 7]. With regard to a 
more sustainable and less polluting production process 
and a regio- and stereoselective oxyfunctionalization at 
C21, the focus has shifted from the chemical process to 
an enzyme based biotechnological production of medrol 
and its precursor. A promising candidate for the enzy-
matic reaction is the mammalian cytochrome P450 
21-hydroxylase (CYP21A2), which is a member of the 
cytochrome P450 (CYP, P450) superfamily. CYP21A2 is 
a protein of the endoplasmic reticulum and plays a cru-
cial role in steroid hormone biosynthesis by providing 
the precursors of the most important mineralocorticoid, 
aldosterone, and the main glucocorticoid, cortisol, via a 
highly selective 21-hydroxylation, which is ensured by 
a unique amino acid arrangement within the active site 
[8–10]. A sufficient electron supply for the hydroxyla-
tion reaction is realized by its natural redox partner, 
the NADPH-dependent cytochrome P450 reductase 
(CPR), a membrane bound protein as well [11, 12]. 
Cytochromes P450 are external monooxygenases and 
exhibit, when reduced and in complex with CO, a unique 
absorption maximum at 450  nm due to the cysteinate 
coordinated heme group at the active site [13]. Their 
ability to functionalize molecular oxygen empowers 
them to catalyze a broad range of reactions, such as 
hydroxylations and even a chemically difficult to perform 
C–C bond cleavage. Apart from steroid hormone bio-
synthesis, they act as main detoxifying enzymes in the 
liver and are, therefore, involved in xenobiotics and drug 
metabolism. P450s are able to convert a great variety of 
substrates like steroids, terpenes as well as fatty acids, 
which shows their high potential as versatile biocatalysts 
[14, 15]. Since the 1960s, cytochromes P450 are crucially 
involved in the glucocorticoid synthesis in large scale by 
fermentation of species of the fungus Curvularia, whose 
later characterized P450 system was shown to be able to 
convert 11-deoxycortisol to cortisol [16–18]. In 2003, 
the application of a modified Saccharomyces cerevisiae 
strain was published, which performs cortisol pro-
duction from a simple carbon source [19]. Aside from 
genetic manipulation of the yeast’s ergosterol synthesis 
pathway, CYPs involved in steroid hormone synthesis, 
including CYP21A2, were expressed in this yeast strain, 
which shows the high importance of these enzymes for 
stereo- and regioselective steroid hydroxylation. To date, 
CYPs find their application in various industrial produc-
tion processes and the number is still growing. Efforts 
are made to design whole-cell systems with single CYPs 
for the desired reaction in a suitable host to avoid by-
products originating from homologous CYP systems like 
in case of C. lunata. Previously, a heterologous human 
CYP11B1 whole-cell system for a more selective cor-
tisol production has been published [20]. Biocatalysis 
with whole cells ensures a better protein stability and a 
supply with costly cofactors, such as NADPH [21]. Con-
cerning mammalian CYP21A2, a whole-cell system in 
the yeast Schizosaccharomyces pombe was already estab-
lished with human CYP21A2, but with limited success 
due to a low recombinant protein yield and the host’s 
long lasting generation time [22]. In other approaches to 
develop CYP based whole-cell systems, Escherichia coli 
emerged to be a suitable host attributed to its short gen-
eration time and the lack of intrinsic CYP systems [23]. 
Functional bovine CYP21A2 could already be success-
fully expressed with high yield in E. coli [24, 25]. These 
fundamentals were the starting point for our efforts to 
establish an efficient CYP21A2-based whole-cell system 
in E. coli for the production of premedrol, the precursor 
of medrol, via a simple one-step hydroxylation at C21. In 
the following, we demonstrate the successful expression 
and purification of bovine CYP21A2 and in  vitro stud-
ies concerning the substrate-protein-interaction, the 
development of a biotransformation in whole cells and 
an improvement of the biocatalytic efficiency by using 
alternative redox systems for a more sufficient electron 
supply.
Results and discussion
Protein purification and in vitro characterization
Purification of bovine CYP21A2
Since bovine CYP21A2 could already be expressed in E. 
coli, we chose this mammalian CYP21A2 isoform for the 
initial examination of its suitability for a whole-cell sys-
tem in E. coli. To ascertain whether bovine CYP21A2 is 
able to convert medrane to premedrol by a stereoselec-
tive 21-hydroxylation, the protein had to be expressed 
and purified according to Arase et  al. [24]. The cDNA 
was subcloned into a pET17b vector, resulting in the vec-
tor pET17b_21b. The vector was co-transformed with 
the vector pGro12, which encodes for the E. coli chap-
erones GroEL/ES, into C43(DE3) cells. After protein 
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expression, cell lysis took place via sonification for the 
subsequent purification. The purification was performed 
via IMAC, anion and cation exchange chromatography 
and the protein was analyzed by SDS-PAGE, confirming 
the estimated molecular weight of 54.6 kDa, and by CO 
difference spectroscopy, which confirmed a correct inser-
tion of the heme prosthetic group by showing a typical 
absorption maximum at 450 nm without a hint of inac-
tive protein, indicated by a peak at 420 nm (Fig. 1). Taken 
together, the expression as well as the purification of 
bovine CYP21A2 was successful with an expression level 
of max. 398 nmol L−1 culture. The purified enzyme was 
used for further investigations.
In vitro conversion of medrane with purified CYP21A2
In order to prove a selective conversion of medrane 
to premedrol by a 21-hydroxylation, in  vitro assays 
were carried out to perform a proof-of-principle, 
as medrane exhibits slight modifications within the 
steran skeleton compared with the natural CYP21A2 
substrates progesterone (P4) and 17OH-proges-
terone (17OH-P4). Hence, substrate conversion 
with purified bovine CYP21A2 was performed with 
the synthetic substrate medrane characterized by 
its additional methyl group at carbon atom 6 and a 
hydroxyl group at carbon atom 11 compared with the 
natural substrate 17OH-P4. HPLC analysis revealed 
a 21-hydroxylation of medrane and demonstrated a 
stereoselective production of the wished product pre-
medrol in an efficient biocatalytic one-step hydroxy-
lation without by-product formation (Fig.  2b). It has 
been shown that bovine CYP21A2 is able to hydrox-
ylate a synthetic substrate of high pharmaceutical 
interest.
Development of a whole‑cell system for a biocatalytic 
premedrol production
After a conversion of medrane to premedrol by purified 
CYP21A2 was verified in  vitro, the subsequent experi-
ments focused on an establishment of a biotransfor-
mation using whole cells, showing advantages like an 
improved enzyme stability and the supply of costly co-
factors by the cell itself [21]. For the development of a 
whole-cell system, the bicistronic vector p21b_bRED was 
constructed, carrying the cDNAs for bovine CYP21A2 
and CPR (Fig.  3). The natural redox partner CPR is 
responsible for electron supply in the endoplasmic retic-
ulum through protein interaction. Cells were co-trans-
formed with the respective vector and with the plasmid 
pGro12, encoding the chaperones GroEL/ES to ensure 
a proper folding of the membrane proteins CYP21A2 
and CPR [26]. Although complex medium is suitable 
for bacterial cell growth and supports a high expression 
yield of recombinant proteins, it is inappropriate for 
whole-cell biotransformations with cytochromes P450 
due to inhibitory effects of medium compounds and E. 
coli metabolites such as indole [27, 28]. For this reason, 
biotransformation with whole cells was performed with 
resting cells using potassium phosphate buffer as a con-
version medium. As the metabolism, including protein 
biosynthesis, of resting cells is reduced to a minimum, 
more co-factors like NADPH can be recruited for the 
CYP dependent reaction [29]. By the addition of glycerol 
to the reaction mix, an NADPH-regeneration is ensured 
by the activity of metabolic enzymes like the isoci-
trate dehydrogenase. For initial examination, medrane 
was added to the whole-cell system and samples were 
taken after 24  h for HPLC analysis. Medrane was con-
verted to premedrol by the constructed system without 
Fig. 1 Protein analysis of purified bovine CYP21A2 after three chromatographic steps. a SDS‑PAGE analysis and protein staining shows the puri‑
fication steps of CYP21A2 via IMAC, DEAE‑ and SP‑Sepharose resulting in a single protein band with a size of approx. 55 kDa (estimated weight: 
54.6 kDa); b Difference spectroscopy of purified bovine CYP21A2 was performed showing a typical absorption maximum at 450 nm in the reduced 
state in complex with CO
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by-product formation, verifying the highly specific 
21-hydroxylation not only with purified enzymes but also 
by a biotransformation with whole cells (Fig.  2a). With 
a substrate concentration of 250  µM, a maximum pre-
medrol yield of 93 mg L−1 d−1 could be achieved. Since 
the human CYP21A2 isoform shares a 79  % sequence 
homology to the bovine one, we additionally tested the 
human CYP21A2 isoform concerning its ability to pro-
duce premedrol. Just as the bovine enzyme, it performs 
a selective 21-hydroxylation of medrane, but exhibits 
a poor yield with 40  mg  L−1  d−1 (Additional file  1: Fig. 
S1). Therefore, we concentrated on the bovine isoform in 
further experiments to improve the whole-cell system’s 
efficiency.
Improvement of the whole‑cell system by using different 
redox partners
CYP involved whole-cell systems require an efficient 
cytochrome P450/redox partner interaction to ensure 
a sufficient electron supply for the hydroxylation reac-
tion [15]. Therefore, a stabilized redox partner synthesis 
as well as an optimal interaction with the CYP should be 
intended. In the following, we focused on these aspects 
by testing various redox systems of different origin.
Selection of alternative redox partners for CYP21
Bovine membrane-bound microsomal CPR represents 
the naturally occurring redox partner for CYP21 in the 
endoplasmic reticulum and was therefore the first choice 
for a co-expression in a whole-cell system. Though, this 
protein is difficult to produce recombinantly due to its 
property as a membrane protein. Therefore, efforts were 
undertaken to search for alternative redox partners of the 
bovine CYP21A2, which are easily expressed in E. coli in 
sufficient amounts, more stable and solvent resistant. On 
this account, we concentrated on the participating pro-
teins of three naturally occurring redox systems, each 
consisting of two components, a ferredoxin or flavodoxin 
reductase and a ferredoxin as final electron donor for 
CYP21A2.
First, we focused on the soluble ferredoxin adreno-
doxin (Adx), which reconstitutes the mitochondrial 
electron transfer system together with the membrane 
associated adrenodoxin reductase (AdR), which receives 
electrons from NADPH [12, 30–32]. This system is 
responsible for the electron supply of the mitochondrial 
Fig. 2 HPLC chromatograms of the in vivo and in vitro conversion of medrane with bovine CYP21A2 and CPR. a Medrane was converted with rest‑
ing cells of C43(DE3) containing the bovine CYP21A2 isoform and CPR encoding vector p21b_bRED. Samples were taken after 24 h and extracted 
for HPLC analysis. The steroids were separated by an acetonitril:water gradient. b Substrate conversions of medrane were performed with purified 
bovine CYP21A2 and its redox partner CPR for 30 min. Steroids were extracted and analyzed by HPLC to verify a selective conversion of medrane to 
premedrol. The steroids were separated by an acetonitril:water gradient, showing the 21‑hydroxylated product premedrol
Fig. 3 Vector map of p21b_bRED containing the bicistronic tran‑
scription unit for bovine CYP21A2 and the CPR. For the whole‑cell 
biotransformation, this bicistronic vector was constructed, based on 
the pET17b vector with a T7 promoter and an ampicillin resistance 
gene. The CPR cDNA encodes for the full length protein
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CYPs, CYP11A1, CYP11B1 and CYP11B2, which are 
also involved in steroid hormone biosynthesis. Pechurs-
kaya et al. showed, that Adx is able to transfer electrons 
to purified CYP21A2, in the case of truncated CYP21A2 
even more effectively than the CPR in in vitro assays [33]. 
In this work, we used the Adx version, Adx1–108, which 
exhibits an increased electron transfer efficiency to some 
CYPs [34, 35].
Second, a redox system originating from the fission 
yeast S. pombe and consisting of the adrenodoxin reduc-
tase homologue 1 (arh1) and the ferredoxin domain of 
electron transfer protein 1 (etp1fd) was considered, since 
Ewen et al. showed that this system is able to substitute 
Adx and AdR regarding an electron transfer to CYP11A1 
[36]. In S. pombe, arh1 and etp1fd are involved in heme 
biosynthesis in the mitochondrium [37]. Etp1fd as iron-
sulfur protein is highly homologous to adrenodoxin and 
is able to transfer electrons to mammalian steroidogenic 
CYPs [38, 39]. Here, we used the truncated version of 
etp1fd (516–618). Both proteins can be produced as cyto-
solic proteins in E. coli. Furthermore, it has been dem-
onstrated, that arh1 can be reduced not only by NADPH 
like AdR, but also by NADH and that arh1 of S. cerevi-
siae is able to interact with bovine Adx [40]. Regarding 
a whole-cell system, a second electron pool could be of 
great advantage for a more efficient hydroxylation rate 
[36]. Janocha et  al. already demonstrated a biotechno-
logical application of arh1 and etp1fd from S. pombe with 
CYP105A1 from Streptomyces griseolus [41]. As in previ-
ous works of our laboratory, we used an arh1 variant with 
an improved FAD-binding behavior, ensuring co-factor 
stability [36].
Third, we applied the E. coli NADPH-flavodoxin reduc-
tase Fpr as an alternative reductase for a whole-cell sys-
tem. It has been demonstrated previously that the soluble 
Fpr is able to transfer electrons to Adx and, therefore, 
represents an efficient substitution for AdR [27]. The Fpr 
together with flavodoxin A (FldA) is part of an E. coli 
redox system, which is involved in biosynthetic processes 
such as amino acid synthesis [42, 43].
To verify whether Adx and etp1fd as final electron 
transfer proteins are able to supply CYP21A2 with elec-
trons, in vitro assays were carried out with different com-
binations of reductases and ferredoxins, listed in Table 1. 
HPLC analysis revealed, that both, Adx and etp1fd, are 
able to transfer electrons to CYP21A2, no matter which 
reductase was chosen (Fig. 4). It was shown for the first 
time, that etp1fd is able to interact with CYP21A2 and, 
furthermore, to recruit the E. coli reductase Fpr as redox 
partner. 
In the following, we show efforts to exchange the nat-
ural redox partner CPR by bovine Adx as well as etp1fd 
as final electron donors in combination with different 
reductases in a whole-cell system to achieve an enhanced 
premedrol yield.
Construction of vectors for a whole‑cell system with various 
redox chains
We constructed three vectors with a tricistronic tran-
scription unit, each containing Adx as final electron 
donor. The vector p21b_ArAx was constructed con-
taining the ORF for bovine CYP21A2, followed by the 
ORF for bovine AdR and Adx1–108, which represents the 
mitochondrial redox chain. Then, we replaced the AdR 
sequence with the one for arh1 from S. pombe. Finally, we 
used the E. coli reductase Fpr instead of AdR. The three 
resulting constructs are shown in Fig. S2 (Additional 
file 2).
Two more vectors were constructed, containing etp1fd 
as electron donor of CYP21A2, on the one hand in com-
bination with its natural ferredoxin reductase from S. 
pombe, arh1 (p21b_ArEt), on the other hand with the E. 
coli reductase, Fpr (p21b_FrEt). The resulting constructs 
are shown in Fig. S3 (Additional file  3). All constructed 
vectors are listed in Table 1.
Evaluation of the CYP21A2 whole‑cell systems with different 
redox partners
C43(DE3) cells were co-transformed with pGro12 and 
the constructed vectors, cultivated simultaneously to 
compare the initial productivity of each system as well 
as the endpoint yield of premedrol. Whole-cell biotrans-
formation was carried out with resting cells in potassium 
phosphate buffer and samples for HPLC analysis were 
taken after 0, 2, 4, 6, 10 and 24 h to get a characteristic 
time course of the product formation depending on the 
respective redox system. A substrate concentration of 
500  µM medrane was applied. HPLC analysis verified 
the biotransformation ability of each system. Regarding 
the endpoint yield, the systems containing the mitochon-
drial (AdR/Adx) and microsomal (CPR) redox partners 
produced the lowest amount of premedrol with 41 and 
Table 1 Vectors for the E. coli whole-cell system
Six pET17b based vectors were constructed, each carrying the CYP21A2 cDNA, in 
either a bicistronic construct with the cDNA for CPR or in a tricistronic construct 
with the cDNAs for Adx1–108 or etp1
fd as final electron donors. The origin of the 
respective protein is mentioned
Vector Reductase Origin Ferredoxin Origin
p21b_bRED CPR Bos taurus
p21b_AdAx AdR Bos taurus Adx Bos taurus
p21b_ArAx arh1 S. pombe Adx Bos taurus
p21b_FrAx Fpr E. coli Adx Bos taurus
p21b_ArEt arh1 S. pombe etp1fd S. pombe
p21b_FrEt Fpr E. coli etp1fd S. pombe
Page 6 of 14Brixius‑Anderko et al. Microb Cell Fact  (2015) 14:135 
87 mg L−1 d−1, respectively. Taken the fact into account 
that AdR and CPR are membrane-associated and mem-
brane-bound proteins, respectively, the recombinant 
synthesis and stability of these enzymes might be limited 
and, therefore, could represent a disadvantage for their 
application in a biotransformation process. Remark-
ably, the endpoint yield was dependent on the expressed 
reductases and not on the respective ferredoxin, suggest-
ing that within this whole-cell system the functionality of 
the reductases is a limiting factor. The biotransformation 
overall yield with Fpr was higher than that with CPR with 
127 and 115  mg  L−1  d−1, no matter which ferredoxin, 
Adx or etp1fd, was the final electron donor for CYP21. 
The same was observed with arh1 as reductase with 
156 mg L−1 d−1 together with Adx and 167 mg L−1 d−1 
with its natural redox partner etp1fd, emphasizing that 
the soluble proteins, Fpr and arh1, are more suitable for a 
whole-cell system (Fig. 5; Table 2). 
Though the endpoint yields of the different systems are 
similar when using the same reductase, the time course 
revealed a crucial difference regarding reaction velocity. 
While the velocities of the redox partner combinations 
arh1/Adx, Fpr/Adx and Fpr/etp1fd are similar within the 
first 4  h, the system containing the reductase as well as 
the ferredoxin from S. pombe exhibits a higher efficiency 
with about doubled product formation between 2 and 
4  h of substrate conversion, obviously due to the fact 
that arh1 together with etp1fd represents a natural redox 
chain with optimal protein–protein interaction proper-
ties. Table 2 lists the initial and final product formation 
rates.
Taken together, we clearly demonstrated, that a redox 
protein exchange for the CYP21 whole-cell system 
increased the overall yield from about 90 mg L−1 d−1 to 
about 167 mg L−1 d−1, by use of arh1 and etp1fd instead of 
CPR. It was also demonstrated that the reaction velocity 
is strongly dependent on the expressed redox proteins. 
With a substrate concentration of 1  mM medrane we 
could maximize the premedrol yield to 320  mg  L−1  d−1 
with the arh1 and etp1fd redox chain in subsequent 
experiments. The fact that arh1 is able to receive elec-
trons not only from NADPH but also from NADH (Addi-
tional file 3: Fig. S3) emphasizes the great potential of this 
reductase in a whole-cell application tapping an addi-
tional electron pool compared with the NADPH depend-
ent Fpr and AdR, taking into account the fact that in E. 
coli NADH is the predominant co-factor under normal 
metabolic conditions of E. coli [44, 45].
To compare our established E. coli system with the 
human CYP21A2 based whole-cell system in S. pombe, 
we performed substrate conversions with the natural 
substrate 17OH-progesterone, since Zehentgruber et  al. 
used it in an S. pombe whole-cell system [22]. With the E. 
Fig. 4 HPLC chromatograms of the in vitro biotransformation of medrane with bovine CYP21A2 and Adx or etp1fd as final redox partner. Substrate 
conversions of medrane were performed with purified bovine CYP21A2 and a Adx as final electron donor, here with its natural reductase AdR, and 
b etp1fd as final electron donor, here with its natural reductase arh1 for 30 min. Steroids were extracted and analyzed by HPLC to verify a selective 
conversion to premedrol, respectively
Fig. 5 Time‑dependent premedrol formation by different CYP21A2 
based whole‑cell systems. Whole‑cell biotransformation was per‑
formed with all constructed systems simultaneously by using resting 
cells. Samples were taken after 0, 2, 4, 10 and 24 h and analyzed via 
HPLC. The premedrol yield at several time points was determined 
for each system. All values represent the mean of triplicates with the 
respective standard deviation
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coli system we achieved 308 ± 16 mg L−1 d−1 of the prod-
uct 11-deoxycortisol, which is an about fourfold higher 
product yield compared with the system in S. pombe pro-
ducing 77 mg product per L and day. Taken into account 
that Zehentgruber et al. used a cell density of 360 g L−1, 
which is tenfold higher than the applied E. coli density 
of 24  g  L−1, we achieved a productivity of 37  µmol g−1 
cell wet weight, while only 0.625 µmol g−1 cell wet weight 
were produced with the S. pombe system, which is 60 
times less. This data clearly demonstrates the high effi-
ciency and productivity of the established E. coli whole-
cell system.
To examine the stoichiometry of CYP21A2:arh1:etp1fd, 
which are encoded by a tricistronic transcription unit, 
Western blot analysis was carried out for each enzyme 
after an expression time of 28  h according to Janocha 
et  al. [41]. The highest expression level was determined 
for etp1fd with approx. 880 nmol L−1. The reductase arh1 
expression level is estimated to be approx. 498 nmol L−1 
and the lowest one is for CYP21A2 with approx. 
119  nmol  L−1. Thus, the proteins are expressed with a 
ratio of 1:4:7 (CYP21A2:arh1:etp1fd) demonstrating an 
excess of reductase and ferredoxin, which supports a suf-
ficient electron supply to CYP21A2 and underlines the 
system’s high efficiency (Fig. 6).
Determination of dissociation constants by difference 
spectroscopy
To compare the binding ability of bovine CYP21A2 to 
the synthetic substrate medrane to natural ones, pro-
gesterone and 17OH-progesterone, and to examine a 
possible limitation for medrane conversion due to a 
decreased protein binding, we determined the disso-
ciation constant of the CYP21A2-medrane complex by 
difference spectroscopy. Complex formation between 
a potential substrate and CYP21A2 is spectroscopi-
cally detectable as type I shift due to the replacement 
of the heme coordinated H2O molecule. Titration of 
CYP21A2 with increasing amounts of medrane shows a 
typical type I shift (Fig.  7a) and, therefore, underlines a 
medrane conversion by CYP21A2. The difference of the 
absorbance maximum and minimum plotted against 
the substrate concentration of each titrating step results 
in a hyperbolic regression curve revealing a KD value of 
11.27 ± 0.28 µM for medrane. To compare the KD value 
Table 2 Premedrol yield of  different systems for  whole-
cell biotransformations performed with  bCYP21A2 
and various redox chains
The premedrol overall yield was determined via HPLC analysis after 24 h 
conversion with all constructs simultaneously. The initial rate was calculated 
taking the first 2 h into account after starting the reaction by substrate addition. 
All values represent the mean of triplicates with the respective standard 
deviation




CPR 87 ± 5 13 ± 2
AdR/Adx 41 ± 6 3 ± 0.2
arh1/Adx 156 ± 2 36 ± 1
Fpr/Adx 127 ± 7 33 ± 2
arh1/etp1fd 167 ± 5 67 ± 4
Fpr/etp1fd 115 ± 1 31 ± 0.4
Fig. 6 Western blot analysis of CYP21A2 and redox proteins in the whole‑cell system for determination of the stoichiometric ratio of the three pro‑
teins encoded by the tricistronic construct p21b_ArEt. Western blot analysis was performed with polyclonal antibodies against a etp1fd (11.3 kDa), 
b arh1 (51 kDa), c bovine CYP21A2 (54.6 kDa). In each blot, lane 1 represents the E. coli cell extract expressing arh1, etp1fd and CYP21A2 after 28 h. 
a lane 2–8 represents purified etp1fd in increasing amounts (10, 20, 30, 40, 50, 75 and 100 ng), b, c The lanes 2–7 show purified arh1 and CYP21A2 
in increasing amounts (arh1: 25, 50, 75, 125, 187.5 and 250 ng, CYP21A2: 24, 48, 95, 143, 191 and 239 ng). The with “M” marked lanes all represent a 
prestained protein marker. The relative lane intensities, which correlate with the respective protein masses, were determined and compared to the 
intensity of the whole‑cell system sample. Mass values were converted into the amount of substances and extrapolated to the expression yield per 
liter culture. Note that etp1fd is known to give a single band in the range of the double mass expected to see on the SDS‑PAGE
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of the non-natural substrate medrane with those of the 
natural substrates, 17OH-progesterone and progester-
one, we additionally titrated CYP21A2 with increasing 
amounts of these steroids. Hyperbolic regression resulted 
in a KD value for 17OH-progesterone of 0.14 ± 0.01 µM 
and for progesterone of 0.34 ± 0.01 µM (Fig. 7b, c), impli-
cating a higher affinity of natural CYP21A2 substrates 
compared with the synthetic one, which is due to the 
amino acid arrangement in the active site of CYP21A2 
to ensure a selective 21-hydroxylation of the natural 
substrates [10]. Considering the nearly 100-fold higher 
KD value of medrane compared with the natural sub-
strate 17OH-P4, an enzyme improvement could aspire 
a stronger binding of the synthetic substrate to promote 
a more efficient premedrol production. This hypothesis 
is underlined by a higher product formation when using 
17OH-progesterone as a substrate displaying a yield of 
889 ± 59 µM d−1 11-deoxycortisol compared with a pre-
medrol yield of 640 ± 13 µM d–1. Hence, biotransforma-
tion with CYP21A2 using the natural substrate with the 
lowest dissociation constant shows a 40 % higher product 
formation than bioconversion with medrane.
Scale‑up of the whole‑cell system with CYP21A2 and the 
redox partners arh1 and etp1fd
After the establishment of a CYP21A2 based whole-
cell system and a further improvement of the system’s 
efficiency by alternative redox chains in shaking flasks, 
we pursued a scale-up of the system by a fermentation 
approach with increased cell density and the possi-
bility to supplement oxygen by the stir velocity, since 
a sufficient oxygen supply is indispensable for CYP 
Fig. 7 Determination of dissociation constants (KD values) with different substrates titrated to CYP21A2. Dissociation constants for a medrane, b 
progesterone and c 17OH‑progesterone were determined by titration of bovine CYP21A2 with increasing concentrations of the particular substrate 
leading to a typical type I shift. Hyperbolic regression resulted in the respective KD values, indicating the extent of the binding affinity towards the 
enzyme
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dependent reactions. Therefore, we performed a scale-
up of the most efficient whole-cell system consisting of 
bovine CYP21A2 and the heterologous redox partner 
proteins arh1 and etp1fd. Protein expression was per-
formed in Erlenmeyer flasks, and after a washing step 
the cell density for the biotransformation was adjusted 
to 72  g  L−1. The reaction took place in the bioreac-
tor BiostatQ® with 500  mL resting cells in a defined 
buffer medium. 1000  mg medrane were added and 
the reaction was performed for 20 h with a stir veloc-
ity of 700  rpm. With this simple scale-up approach 
from a reaction volume of 25  mL in shaking flasks up 
to 500  mL in a bioreactor, a higher cell density was 
reached and a maximum product yield of 0.65  g pre-
medrol per L  d−1 could be achieved. Considering the 
reaction’s time dependence it was shown that the initial 
rate of 88  mg  L−1  h−1 within the first 3  h dropped to 
15 mg L−1 h−1 within the last 15 h of the biotransfor-
mation (Fig.  8). The decrease of the reaction rate was 
already observed in shaking flasks and in other CYP 
dependent whole-cell systems indicating limiting fac-
tors for a continuous biotransformation [46]. In case 
of CYP21A2, protein stability as a limiting factor could 
be excluded by CO difference spectroscopy of samples 
taken before and after bioconversion, which showed a 
highly stable enzyme (Additional file  4: Fig. S4). Fur-
thermore, we could confirm by Western blot analysis 
that there exists an optimal stoichiometry of CYP21A2 
and the redox proteins arh1 and etp1fd. Regarding a 
biotechnological application the next step would be 
the establishment of a controlled fermentation process 
ensuring a stable pH, carbon source as well as substrate 
feeding and, overall, a sufficient supply with oxygen 
needed for a CYP catalyzed reaction. Nevertheless, this 
scale-up approach implicates the potential to increase 
the whole-cell system’s efficiency by a biotransforma-
tion in a bioreactor and already produced nearly gram 
amounts of product per liter and day (Additional file 5: 
Fig. S5, Additional file 6: Table S1).
Conclusions
In this work, we demonstrated that the mamma-
lian CYP21A2, which is involved in mammalian ster-
oid hormone biosynthesis and catalyzes a stereo- and 
regioselective 21-hydroxylation of progesterone and 
17OH-progesterone, also exhibits a high potential as 
biocatalyst for medrol production. It could be demon-
strated with purified enzyme as well as in a newly estab-
lished E. coli whole-cell system that CYP21A2 is able to 
convert medrane to premedrol, an important precursor 
of medrol, via a selective oxofunctionalization at C21. 
Since a sufficient electron supply is an essential fac-
tor influencing CYP dependent reactions, the focus has 
shifted from the natural CYP21A2 redox partner, the 
membrane protein CPR, to alternative redox proteins. 
Therefore, five different redox systems were introduced 
and examined regarding velocity and endpoint yield. The 
systems containing the ferredoxin reductase arh1 from 
S. pombe were similar in their endpoint independent on 
the used ferredoxin. With regard of the initial reaction 
rate it is shown in Fig.  5, that the redox chain consist-
ing of arh1 and its natural ferredoxin etp1fd is two times 
faster than all other systems, possibly due to the fact 
that the electron transfer between a natural redox pair is 
much more effective and faster than in the system with 
Adx (Fig. 5; Table 2). Taken together, the use of soluble 
enzymes with a high expression yield seems to be the 
best choice for the system’s stability and effectiveness, 
which is underlined by an ideal protein stoichiometry, 
confirmed by Western blot analysis of the three par-
ticipating proteins (Fig. 6). Compared to the CPR based 
system the premedrol yield could be enhanced about the 
3.6 fold by the use of other redox partners, which shows 
the high impact of a sufficient, stable and suitable elec-
tron supply during biotransformation. We could achieve 
320 mg L−1 d−1 in shaking flasks experiments. A scale-
up approach to 500  mL in a bioreactor, including an 
increase of the cell density, could further improve the 
overall yield up to a maximum of 0.65 g L−1 d−1 which 
shows the potential of the system for an industrial appli-
cation and an important step towards the replacement 
of the chemical premedrol synthesis by a biocatalytic 
approach.
Fig. 8 Time‑dependent premedrol formation by the CYP21A2 based 
whole‑cell system with arh1 and etp1fd in a bioreactor. Whole‑
cell biotransformation in a bioreactor was performed with cells of 
C43(DE3), transformed with the vector p21b_ArEt, which is encoding 
bovine CYP21A2 as well as arh1 and etp1fd, by using resting cells 
in a volume of 500 mL and a cell density of 72 g L−1. Samples were 
taken after certain time points and analyzed via HPLC to examine the 
temporal premedrol increase
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Methods
Chemicals, kits, enzymes and primary antibodies
All chemicals were from standard sources and of highest 
purity. Solvents used for chromatographic analysis were 
of gradient grade. Steroids for analysis and whole-cell bio-
transformation were from Sanofi, Frankfurt-Höchst (DE) 
and of highest purity. Restriction enzymes were obtained 
from New England Biolabs (Frankfurt, DE), kits for plas-
mid preparation and DNA purification from Machery-
Nagel (Düren, DE) and the FastLink™ DNA Ligation Kit 
from Epicentre Biotechnologies (Madison, US). The pri-
mary antibody against arh1 was obtained from Charles 
River Laboratories (Sulzfeld, Germany), against etp1fd 
from BioGenes (Berlin, Germany) and against bovine 
CYP21A2 from antikoerper-online.de (Aachen, Germany).
Bacterial strains and cultivation
Plasmid preparation and cloning experiments were car-
ried out with E. coli TOP10 (Invitrogen, San Diego, 
CA, USA). Protein synthesis and whole-cell biotrans-
formation were performed with E. coli strain C43(DE3) 
[47]. The cultivation took place in Luria–Bertani broth 
(BD, Heidelberg, DE) or in terrific broth (TB) complex 
medium. Transformed cells were stored as glycerol stock 
with a 1:1 mixture of an overnight culture and glycerol 
(50 %) at −80 °C.
Molecular cloning
Expression vector for bovine and human CYP21A2
The cDNAs for bovine and human CYP21A2 was con-
structed according to Arase et  al. with a replacement of 
the N-terminal hydrophobic anchor region with MAKK 
TSSKGK from CYP2C3 and a 6× Histidin tag for pro-
tein purification [24, 48]. It was digested with NdeI and 
BamHI and ligated into the pET17b expression vector 
(Novagen). The constructed vectors are subsequently des-
ignated as pET17b_21b and pET17b_21h.
Construction of vectors for a whole‑cell biotransformation
All constructed vectors for a whole-cell biotransforma-
tion are based on the pET17b expression vector. All con-
structs consist of bi- or tricistronic transcription units 
with the CYP21A2 cDNA sequence and one or two redox 
partner cDNAs downstream of it (Fig. 2, Additional file 1: 
Fig S1, Additional file 2: S2).
The vector pET17b_21b served as a backbone for the 
construction of the vector p21b_bRED, containing the 
cDNA for bovine CYP21A2 and its natural redox partner, 
the bovine cytochrome P450 reductase (CPR), as a bicis-
tronic transcription unit. A CPR containing vector was 
used for PCR amplification of CPR cDNA [49]. The for-
ward primer contains a BamHI restriction side followed 
by a ribosomal binding side and the respective coding 
region. The appropriate reverse primer carries the C-ter-
minal coding region including the stop codon and a NotI 
restriction side. The PCR product was digested and ligated 
between the BamHI and NotI sides of pET17b_21b, 
resulting in the bicistronic construct p21b_bRED. The 
vector p21h_bRED was cloned likewise.
The vector p21b_AdAx contains a tricistronic transcrip-
tion unit, consisting of the cDNA for bovine CYP21A2, 
bovine adrenodoxin reductase (AdR) and truncated bovine 
adrenodoxin (Adx1–108). Bovine AdR and Adx represent 
the mitochondrial redox system, which is proved to inter-
act with CYP21A2. The vector Twin11B1 served as a back-
bone for the construction and carries the cDNA for human 
CYP11B1, bovine AdR and bovine Adx in a tricistronic 
arrangement [20]. Firstly, an undesired HindIII site had to be 
removed within the CYP21A2 sequence by QuikChange® 
Site-Directed Mutagenesis. The resulting cDNA for bovine 
CYP21A2 was amplified by PCR with pET17b_21b as a 
template. The forward primer is equal to the existing DNA 
sequence and contains an NdeI restriction site. The reverse 
primer carries the end of the coding region and a HindIII 
site. Both PCR product and the vector Twin11B1 were 
digested and the CYP21A2 cDNA was ligated between the 
NdeI and HindIII sites of Twin 11B1 by a replacement of 
the CYP11B1 sequence against the CYP21A2 cDNA which 
results in the tricistronic vector p21b_AdAx.
The vector p21b_FrAx was constructed according 
to p21b_AdAx and contains the E. coli reductase Fpr 
instead of AdR, which is cloned through the HindIII and 
KpnI sites. Origin of the Fpr sequence was the vector 
pET_MR6 [27].
For cloning of the vectors harboring components of 
the redox system from S. pombe the vector pBar_Twin_
pombe served as a template, carrying the cDNA for 
adrenodoxin reductase homologue 1 (arh1) and the 
ferredoxin domain of the electron transfer protein 1 
(etp1fd) [36, 38, 41]. In a first step, the AdR sequence of 
the vector p21b_AdAx was replaced by the arh1 cDNA 
which was amplified via PCR using pBar_Twin_pombe as 
a template. The forward primer carried a HindIII restric-
tion site as well as a following ribosomal binding site 
while the reverse primer was identical to the C-terminal 
sequence including a KpnI restriction site. The amplified 
PCR product was digested and cloned into the likewise 
digested p21b_AdAx. The resulting vector p21b_ArAx 
contains a tricistronic construct composed of the cDNAs 
for CYP21A2, arh1 and Adx.
In the next step, the vector p21b_ArEt was constructed 
based on the backbone of the vector p21b_ArAx, which con-
tains both components of the S. pombe redox system. Again, 
pBar_Twin_pombe served as a template for a PCR amplifi-
cation of etp1fd. The forward as well as the reverse primer 
were identical to the etp1fd cDNA sequence, carrying a KpnI 
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and an EcoRI restriction site. The PCR product was digested 
and ligated between the KpnI and EcoRI restriction sites of 
the likewise digested p21b_ArAx resulting in an exchange 
of Adx by etp1fd. The vector p21b_FrEt was cloned likewise. 
All used primers are listed in Additional file 6: Table S6.
Protein expression and purification
Expression and purification of electron transfer proteins
Bovine AdR and Adx as well as arh1, Fpr and etp1fd were 
expressed in E. coli and purified as described before [27, 
34, 36, 38, 50].
Bovine CPR was synthesized in E. coli and purified 
via Immobilized Metal Ion Affinity Chromatography 
(IMAC) as described elsewhere [49].
Expression and purification of bovine and human CYP21A2
C43(DE3) were co-transformed with the expression vec-
tor pET17b_21b and the vector pGro12 which carries 
the genes for the molecular E. coli chaperones GroEL/
ES to ensure a proper protein folding and a correct inte-
gration of the heme cofactor. For the seed culture, 10 mL 
LB medium, supplemented with 100  µg  mL−1 ampicillin 
for pET17b_21b selection and 50 µg mL−1 kanamycin for 
pGro12 selection, were inoculated with transformed cells 
from a glycerol stock and grown overnight at 37  °C with 
160 rpm. For the main culture, 250 mL TB medium, sup-
plemented with 100  µg  mL−1 ampicillin and 50  µg  mL−1 
kanamycin, were inoculated with 1/100 (v/v) of the seed 
culture and grown at 37  °C with 190 rpm to an OD600 of 
0.5. At this time point, gene expression was induced by 
adding 1 mM isopropylthiogalactopyranosid (IPTG), 1 mM 
δ-aminolevulinic acid as heme precursor and 4  mg  mL−1 
l-arabinose for the induction of the chaperones GroEL/ES. 
Protein synthesis was carried out at 27 °C with 150 rpm for 
38 h. Cells were harvested at 4,000g for 20 min at 4 °C.
Cell pellets were diluted in lysis buffer, consisting of 
50  mM potassium phosphate buffer (pH 7.4), 500  mM 
sodium acetate, 0.1  mM EDTA, 20  % glycerin, 1.5  % 
sodium cholate, 1.5  % Tween20, 0.1  mM PMSF and 
0.1  mM DTE. Cells were disrupted by sonification and 
centrifuged with 30,000g at 4 °C for 30 min. The superna-
tant was taken for the subsequent purification. The 3 step 
protein purification by Immobilized Metal Ion Affinity 
Chromatography (IMAC) and DEAE Sepharose as well 
as SP Sepharose for ion exchange chromatography was 
done as previously described by Arase et al. [24].
UV/vis spectroscopy
CO difference spectroscopy of reduced CYP in complex 
with CO was carried out for a qualitative and quantitative 
enzyme characterization following the typical absorption 
maximum at 450  nm with an extinction coefficient of 
91 mM−1 cm−1 [13].
Difference spectroscopy was performed to examine 
the binding behavior of CYP21A2 natural and unnatu-
ral CYP21A2 substrates as previously described by using 
tandem cuvettes. CYP21A2 was dissolved in buffer 
(50  mM potassium phosphate (pH 7.4), 20  % glycerol, 
0.5 % sodium cholate and 0.05 % Tween 20) and titrated 
with increasing amounts of substrate in DMSO. Differ-
ence spectra were recorded from 350 to 500  nm. The 
values from three titrations were averaged and the KD 
values were determined by fitting the plots with hyper-
bolic regression or tight binding quadratic equation with 
OriginPro 9.1G [51].
Reconstituted in vitro assays
The in vitro reconstitution assay was performed in a final 
volume of 250  µL with 50  mM HEPES buffer (pH 7.4) 
containing either 100 µM DLPC and 20 % glycerol for the 
CPR or 0.5 % Tween20 for all other redox proteins. The 
final concentration of CYP21A2 was 0.5 µM, the concen-
tration of arh1 and AdR 0.5 µM, of Adx and etp1fd 10 µM, 
of the Fpr 25  µM and of the CPR 1  µM, respectively. 
Additionally, the mixture contained a NADPH regen-
eration system consisting of 5 mM glucose-6-phosphate, 
1  mM MgCl2 as well as glucose-6-phosphate dehydro-
genase. The particular steroid substrate was added in a 
concentration range of 100–400  µM. The reaction was 
started with 5  mM NADPH or NADH and incubated 
shaking for 30–40  min at 37  °C. The assay was stopped 
by addition of 250 µL chloroform, steroids were extracted 
twice with chloroform, dried and stored at −20  °C for 
HPLC analysis.
Whole‑cell biotransformation with different redox systems 
in shaking flasks
Protein synthesis of bovine and human CYP21A2 and the 
respective redox partners for a whole-cell biotransforma-
tion was performed as described above by co-transforma-
tion of C43(DE3) cells with the particular bi-or tricistronic 
vector and the pGro12. After 28  h expression time, cells 
were harvested at 4,000g for 15 min at room temperature. 
The cell pellets were washed with 50 mM potassium phos-
phate buffer and cell wet weight was adjusted to 24 g L−1. 
The whole-cell biotransformation was carried out with 
resting cells in 50  mM potassium phosphate buffer (pH 
7.4) supplemented with 2 % glycerol, 1 mM IPTG, 1 mM 
δ-Ala, 4 mg mL−1 arabinose and 25 µg mL−1 polymyxin B. 
The reaction volume was 25 mL in 300 mL baffled Erlen-
meyer flasks. The steroid substrate was solved in DMSO 
and added in concentrations ranging from 200 to 1.2 mM. 
The whole-cell reaction mixture was incubated at 27  °C 
with 145  rpm for 24  h. Samples for HPLC analysis were 
taken at different time points, extracted twice with chloro-
form, dried and stored at −20 °C.
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Whole‑cell biotransformation in a bioreactor
Protein synthesis of bovine CYP21A2 and the redox part-
ners arh1 and etp1fd for a whole-cell biotransformation was 
performed as described above, by co-transformation of 
C43(DE3) cells with the p21b_ArEt vector and the pGro12. 
After 28 h expression time, cells were harvested at 4,000g 
for 15  min at room temperature. The cell pellets were 
washed with 50 mM potassium phosphate buffer and cell 
wet weight was adjusted to 72 g L−1. The whole-cell bio-
transformation was carried out with resting cells in 50 mM 
potassium phosphate buffer (pH 7.4) supplemented with 
2 % glycerol, 1 mM IPTG, 1 mM δ-Ala, 4 mg mL−1 arab-
inose and 25 µg mL−1 polymyxin B. The reaction volume 
was 500 mL and the biotransformation was carried out in 
the bioreactor BiostatQ® with a stir velocity of 700 rpm at 
27  °C. The steroid substrate was dissolved in DMSO and 
added in concentrations up to 1000 mg L−1.
Steroid analysis via RP‑HPLC
Steroid analysis was carried out by reversed-phase 
high performance liquid chromatography using a Jasco 
reversed phase HPLC system of the LC900 series and a 
4.6 mm × 125 mm NucleoDur C18 Isis Reversed Phase 
column (Macherey–Nagel).
The reconstituted in  vitro assays were analyzed with 
an acetonitril/water gradient at 240 nm within 15 min at 
40 °C and a flow rate of 0.8 mL min−1.
The whole-cell conversion was measured with an ace-
tonitril/water gradient at 240 nm within 30 min at 40 °C 
and a flow rate of 0.8 mL min−1.
Western blot analysis
Samples from the culture, co-expressing bovine CYP21A2, 
arh1 and etp1fd, were taken, adjusted to OD 1 and cen-
trifuged. The pellet was suspended in 100 µl SDS-PAGE 
loading buffer and boiled for 10 min. 6 µL of the sample 
in case of CYP21A2 and arh1 and 3 µL in case of etp1fd 
were separated on a 12  % acrylamide gel according to 
Laemmli et  al. [52]. For Western blot analysis, proteins 
were transferred to hybond-ECL nitrocellulose mem-
branes (Amersham, GE Healthcare, England) [53]. The 
membranes were blocked overnight in 3 % milk powder 
in 30  mL TBS (50  mM Tris–Cl pH 7.5, 400  mM NaCl, 
0.15  % Tween 20). After blocking, the membranes were 
washed three times for 15 min with TBS and afterwards 
incubated for 1.5 h with the respective primary antibody, 
dissolved 1:1000 in TBS. After three following washing 
steps with TBS, incubation with the secondary horserad-
ish-linked goat antirabbit IgG antibody (Dako, Glostrup, 
Denmark), diluted 1:3000 in TBS, took place for 1.5 h. In 
the following step, the membranes were washed three 
times for 15  min with PBS (10  mM potassium phos-
phate buffer pH 7.4, 150 mM NaCl) and afterwards, the 
protein-antibody conjugates were visualized by addi-
tion of 4-chloro-1-naphthol (2 mL; 3 mg/mL in ethanol) 
in 25 mL PBS supplemented with 10 μL H2O2. Relative 
intensity of the protein bands was measured with Image 
Lab 3.0 from BioRad (München, Germany). The deter-
mination of the protein yield was performed by compar-
ing the sample amount (Fig.  6a–c, lane 1) to increasing 
concentrations of purified protein, for etp1fd 10, 20, 30, 
40, 50, 75 and 100  ng (Fig.  6a, lanes 2–8), for arh1 25, 
50, 75, 125, 187.5 and 250 ng (Fig. 6b, lanes 2–7) and for 
bovine CYP21A2 24, 48, 95, 143, 191 and 239 ng (Fig. 6c, 
lanes 2–7). The relative lane intensities, which correlate 
with the respective protein masses, were determined and 
compared to the intensity of the whole-cell system sam-
ple. Mass values were converted into the amount of sub-
stances and extrapolated to the expression yield per liter 
culture.
Additional files
Additional file 1: Fig. S1. HPLC chromatograms of the in vivo and in vitro 
conversion of medrane with human CYP21A2 and CPR. a Medrane was 
converted with resting cells of C43(DE3) containing the human CYP21A2 
isoform and CPR encoding vector p21h_bRED. Samples were taken after 
24 h and extracted for HPLC analysis. The steroids were separated by 
an acetonitril:water gradient. b Substrate conversions of medrane were 
performed with purified human CYP21A2 and its redox partner CPR for 
30 min. Steroids were extracted and analyzed by HPLC to verify a selective 
conversion of medrane to premedrol, respectively. The steroids were 
separated by an acetonitril:water gradient, showing the 21‑hydroxylated 
product premedrol.
Additional file 2: Fig. S2. Vector maps of constructed vectors for a 
CYP21A2 based whole‑cell system in E. coli with Adx as final electron 
donor. Three vectors with tricistronic transcription units were constructed, 
based on the pET17b vector with an inducible T7 promoter and an 
ampicillin resistance gene, with Adx as final electron donor in combina‑
tion with one of the reductases, AdR (p21b_AdAx), arh1 (p21b_ArAx) or 
Fpr (p21b_FrAx).
Additional file 3: Fig. S3. Vector maps of constructed vectors for a 
CYP21A2 based whole‑cell system in E. coli with etp1fd as final electron 
donor. Two vectors with tricistronic transcription units were constructed, 
based on the pET17b vector with an inducible T7 promotor and an ampi‑
cillin resistance gene, with etp1fd as final electron donor in combination 
with the reductases arh1 (p21b_ArEt) or Fpr (p21b_FrEt).
Additional file 4: Fig. S4. In vitro conversion of medrane with the redox 
systems AdR/Adx/CYP21A2 or arh1/Adx/CYP21A2 with either NADH or 
NADPH. 400 μM Medrane was converted in a reconstituted in vitro assay 
with Adx based redox systems containing AdR or arh1 as reductase. To 
each system either NADH or NADPH was added to verify the ability of 
arh1 to receive electrons from NADH. AdR served as a negative control. 
All values represent the mean of triplicates with the respective standard 
deviation.
Additional file 5: Fig. S5. CO difference spectra of bovine CYP21A2 
before and after 24 h biotransformation. Cells were harvested before and 
after 24 hours biotransformation. COD was performed with the respec‑
tive lysate, each showing a typical absorption maximum at 450 nm in a 
reduced state in complex with CO which indicates a correct heme inser‑
tion. The solid line shows the COD before biotransformation, the dashed 
one after 24 h bioconversion in buffer.
Additional file 6: Table S1. Sequences of used primers with indication 
of their purpose. Restriction sites are in bold letters and base exchanges 
are signed in bold and cursive.
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